Maternus-Kliniken AG

Not Rated
  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: DE0006044001
EUR
1.21
0.05 (4.31%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Maternus-Kliniken AG Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
-10.00
-12.00
-15.00
-2.00
-5.00
-10.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
2.00
-1.00
2.00
3.00
1.00
18.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
10.00
-5.00
-1.00
11.00
5.00
8.00
Cash Flow from Investing Activities
-1.00
-3.00
-2.00
-1.00
0.00
0.00
Cash Flow from Financing Activities
-7.00
7.00
-6.00
-6.00
4.00
-8.00
Net Cash Inflow / Outflow
2.00
-1.00
-10.00
2.00
9.00
-1.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in EUR Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Maternus-Kliniken AG
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(EUR)
Change(%)
Profit Before Tax
-10.275
4.138978
-14.00
-348.25%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
2.483
0.791709
2.00
213.63%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
10.786
7.07909
3.00
52.36%
Cash Flow from Investing Activities
-1.074
-4.959962
3.00
78.35%
Cash Flow from Financing Activities
-7.387
0.225947
-7.00
-3369.35%
Net Cash Inflow / Outflow
2.325
2.345075
0.00
-0.86%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
stock-summary

YoY Growth in year ended Dec 2024 is 315.63% vs -247.84% in Dec 2023

Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
10.79
-5.00
315.63%